News from novocure A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 21, 2014, 13:28 ET Novocure meldet PMA-Beantragung in Japan zwecks Zulassung des NovoTTF™-100A-Systems zur Behandlung rezidivierter Glioblastome

-- Japanische Gesellschaft für Neuroonkologie fordert zügige Genehmigung durch das japanische Ministerium für Gesundheit, Arbeit und...


Aug 21, 2014, 12:20 ET Novocure anuncia la entrega de una solicitud de aprobación en Japón para el sistema NovoTTF™-100A

-- Novocure anuncia la entrega de una solicitud de aprobación precomercialización en Japón para el sistema NovoTTF™-100A para...


Aug 21, 2014, 08:00 ET Novocure annonce le dépôt au Japon d'une demande d'autorisation préalable à la mise sur le marché pour le système NovoTTF™-100A utilisé dans le traitement du glioblastome récurrent

-- La société japonaise de neuro-oncologie appelle le ministère japonais de la Santé et du Bien-être (MHLW)...


Aug 21, 2014, 08:00 ET Novocure Announces the Submission of a Pre-Marketing Approval Application in Japan for the NovoTTF™-100A System to Treat Recurrent Glioblastoma

 Novocure, a commercial stage oncology company, announced today that it has submitted the registration dossier for Pre-Market Approval (PMA) of...


Apr 04, 2014, 10:31 ET Novocure présentera de nouvelles données précliniques sur le traitement NovoTTF™ à l'occasion de la réunion annuelle 2014 de l'Association américaine pour la recherche sur le cancer

 Novocure, une société d'oncologie au stade commercial, a annoncé aujourd'hui que de nouvelles données précliniques...


Apr 04, 2014, 08:45 ET Novocure presenta nuevos datos preclínicos sobre la terapia NovoTTF™

- Novocure presenta nuevos datos preclínicos sobre la terapia NovoTTF™ en la reunión anual 2014 de la American Association...


Apr 04, 2014, 08:41 ET Novocure präsentiert neue präklinische Daten zur NovoTTF™-Therapie auf der Jahrestagung 2014 der American Association for Cancer Research

 Novocure, ein kommerzielles Unternehmen aus dem Bereich der Onkologie, gab heute bekannt, dass im Zuge der vom 5. bis 9. April 2014 in San...


Apr 03, 2014, 10:57 ET Novocure to Present New Pre-Clinical Data on NovoTTF™ Therapy at the American Association for Cancer Research Annual Meeting 2014

 Novocure, a commercial stage oncology company, announced today that new, pre-clinical data demonstrating the anti-tumor effects of...


Feb 18, 2014, 09:00 ET Novocure Announces First Commercial License of the NovoTAL™ (Transducer Array Layout) System

  Novocure announced today that Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center has licensed the NovoTAL (Transducer...


Jan 24, 2014, 09:00 ET Novocure Enrolls First Patient in Pilot Clinical Trial of NovoTTF™ Therapy Plus Gemcitabine for First-line Treatment of Advanced Pancreatic Adenocarcinoma

 Novocure announced today that the first patient has enrolled in the EF-20 Study, an open label, pilot clinical trial of NovoTTF Therapy...


Jan 06, 2014, 09:00 ET Data Published in Pancreatology Demonstrates Activity of NovoTTF™ Therapy in Preclinical Models of Pancreatic Cancer, Alone and in Combination with Chemotherapy

 Novocure™ announced today that the first evidence of activity of NovoTTF Therapy in pancreatic cancer tumor models was published online...


Dec 10, 2013, 11:08 ET Centers for Medicare and Medicaid Services (CMS) Has Established Permanent Billing Codes for the NovoTTF-100A System™

 Novocure announced today that the Centers for Medicare and Medicaid Services (CMS) has established new therapy-specific Healthcare Common...


Nov 05, 2013, 09:00 ET Novocure Announces FDA Approval of the NovoTAL™ (Transducer Array Layout) System

 Novocure announced today that the United States Food and Drug Administration (FDA) has approved the NovoTAL (Transducer Array Layout) System...